Drug Approval Package

 Zyban (Bupropion Hydrochloride) Sustained-Release Tablet
Company:  Glaxo Wellcome, Inc.
Application No.:  020711s002/s004
Approval Date: 02/24/1999

• Approval Letter(s) (PDF)    

• Printed Labeling (PDF)    

• Administrative Document(s) & Correspondence (PDF)  

Date created: May 15, 2006

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.